Cell line-derived xenografts

Show results for

Unknown (467)
Genomics (246)
Transcriptomics (180)
Proteomics (33)
Methylation profiling (5)
Other (4)
Metabolomics (4)

Organisms

Homo sapiens (266)
Mus musculus (23)
Chlorocebus aethiops (1)
Rattus norvegicus (1)
synthetic construct (1)
Fusarium sinicum (1)
Canis lupus familiaris (1)
Trypanosoma brucei (1)

Organisms

Homo sapiens (142)
Mus musculus (11)

Repository

ENA (178)
biostudies-arrayexpress (120)
geo (85)
EGA (51)
pride (24)
MassIVE (4)
MetaboLights (4)
iProX (3)
LINCS (2)
GPMDB (1)
jPOST (1)
PAXDB (1)

Tissue

Cell culture (12)
Epithelial cell (5)
Permanent cell line cell (4)
Brain (2)
B-cell lymphoma/leukemia 11B (1)
Blood plasma (1)
Breast (1)
Breast adenocarcinoma cell line (1)
Colon (1)
Ewing's sarcoma cell (1)
Hepatocyte (1)
Mammary gland (1)
Mammary gland epithelial cell (1)
Mammary luminal epithelial cell (1)
Neuroblastoma cell (1)
Neuroblastoma cell line (1)
Oligodendrocyte (1)
Pancreatic cell line (1)
Pancreatic ductal adenocarcinoma cell (1)
Prostate cancer cell line (1)
Skin (1)

Disease

Breast cancer (6)
Melanoma (2)
Colon cancer (2)
Neuroblastoma (2)
Reference (1)
Not Available (1)
B-cell acute lymphoblastic leukemia (1)
Brain cancer (1)
Desmoplastic small round cell tumor (1)
Hepatocellular carcinoma (1)
Kidney cancer (1)
Lung cancer (1)
Malignant neoplasm of ovary (1)
Oligodendroglioma (1)
Osteosarcoma (1)
Pancreatic cancer (1)
Pancreatic ductal adenocarcinoma (1)
Triple-receptor negative breast cancer (1)

Technology Type

Mass Spectrometry (24)
Shotgun proteomics (18)
Mass spectrometry (3)
Bottom-up proteomics (3)
Illumina HiSeq 2000 (2)
Fluorescence imaging (2)
Fluorescence intensity (2)
Data-dependent acquisition (2)
Mass spectrometry assay (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)
SWATH MS (1)

Instrument Platform

NextSeq 500 (5)
Illumina NovaSeq 6000 (4)
Orbitrap Fusion Lumos (3)
Liquid Chromatography MS - positive - reverse phase (2)
Poly-T oligo-attached magnetic beads (1)
PureLink RNA Mini Kit (1)
MoFlo Legacy cell sorter (Beckman Coulter) (1)
PC (1)
NA (1)
Illumina MiSeq (1)
Instrument (1)
MicrOTOF-Q II (1)
Orbitrap Fusion (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - negative - reverse phase (1)
MS Imaging - (1)

Publication Date

2026 (21)
2025 (20)
2016 (20)
2015 (19)
2023 (18)
2014 (18)
2022 (17)
2020 (13)
2011 (12)
2024 (11)
2018 (11)
2013 (11)
2012 (11)
2010 (9)
2008 (8)
2021 (6)
2019 (6)
2017 (5)
2009 (5)
2007 (2)

UNIPROT ID/AC

1433B_HUMAN (1)
1433E_HUMAN (1)
1433F_HUMAN (1)
1433G_HUMAN (1)
1433S_HUMAN (1)
1433T_HUMAN (1)
1433Z_HUMAN (1)
2A5A_HUMAN (1)
2A5D_HUMAN (1)
2A5E_HUMAN (1)
2A5G_HUMAN (1)
2AAA_HUMAN (1)
2AAB_HUMAN (1)
2ABA_HUMAN (1)
2ABD_HUMAN (1)
3BHS1_HUMAN (1)
3HIDH_HUMAN (1)
41_HUMAN (1)
4EBP2_HUMAN (1)
4F2_HUMAN (1)
5HT6R_HUMAN (1)
5NT3A_HUMAN (1)
5NTC_HUMAN (1)
5NTD_HUMAN (1)
6PGD_HUMAN (1)
6PGL_HUMAN (1)
8ODP_HUMAN (1)
9606.ENSP00000233596 (1)
9606.ENSP00000268624 (1)
9606.ENSP00000291295 (1)

CHEBI ID

CHEBI:100241 (1)
CHEBI:10043 (1)
CHEBI:10588 (1)
CHEBI:113 (1)
CHEBI:12962 (1)
CHEBI:131700 (1)
CHEBI:131991 (1)
CHEBI:132553 (1)
CHEBI:132556 (1)
CHEBI:132703 (1)
CHEBI:13332 (1)
CHEBI:136619 (1)
CHEBI:138519 (1)
CHEBI:138532 (1)
CHEBI:138736 (1)
CHEBI:138768 (1)
CHEBI:138800 (1)
CHEBI:138860 (1)
CHEBI:14336 (1)
CHEBI:143728 (1)
CHEBI:145120 (1)
CHEBI:149658 (1)
CHEBI:15245 (1)
CHEBI:15318 (1)
CHEBI:15354 (1)
CHEBI:15356 (1)
CHEBI:15414 (1)
CHEBI:154829 (1)
CHEBI:15553 (1)
CHEBI:155825 (1)

Metabolite Name

(+)-Catechin (1)
(+/-)-cis,trans-abscisic acid (1)
(-)-Epicatechin (1)
(-)-Riboflavin (1)
(2E)-3,4,4,5,5,6,6,7,7,8,8,8-Dodecafluoro-2-octenoic acid (1)
(R)-(-)-Phenylephrine (1)
(S)-(+)-Citramailc acid (1)
(S)-3-Amino-5-methylhexanoic acid (1)
1,3-Dihydroxyacetone dimer (1)
1,4-Androstadiene-3,17-dione (1)
1-(3-Chlorophenyl)piperazine (1)
1-Aminocyclopropane-1-carboxylic acid (1)
1-Isothiocyanato-6-(methylsulfonyl)-hexane (1)
1-Isothiocyanato-7-(methylsulfinyl)-heptane (1)
1-Isothiocyanato-8-(methylsulfinyl)-octane (1)
1-Isothiocyanato-9-(methylsulfinyl)-nonane (1)
1-Methylnicotinamide (1)
1-O-beta-D-Glucopyranosyl sinapate (1)
11,12-EET (1)
12-HEPE (1)
13-HOTrE(r) (1)
17-HDoHE (1)
1H-indole-3-carboxylic acid (1)
2',2'-Difluoro-2'-deoxyuridine (1)
2'-Deoxyadenosine (1)
2'-Deoxyadenosine 5'-monophosphate (1)
2'-Deoxycytidine (1)
2'-Deoxycytidine 5'-diphosphate (1)
2'-Deoxyinosine 5'-monophosphate (1)
2'-Deoxyuridine 5'-monophosphate (1)

First Public Date

2025 (32)
2024 (26)
2026 (25)
2022 (17)
2023 (16)
2020 (13)
2018 (11)
2014 (11)
2017 (8)
2021 (7)
2019 (6)
2015 (3)
2013 (2)
2016 (1)

Study type

Transcription profiling by array (89)
RNA-seq of coding RNA (8)
Genotyping by array (3)
Methylation profiling by array (3)
Spatial transcriptomics by high-throughput sequencing (2)
Comparative genomic hybridization by array (2)
ChIP-seq (2)
RNA-seq of non coding RNA (2)
Cell line - Methylation microarray (1)
Cell line - One-color microarray (1)
Transcription profiling by RT-PCR (1)
Other (1)
MicroRNA profiling by array (1)
DNA-seq (1)
RNA-seq of coding RNA from single cells (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2021 (54)
2022 (48)
2016 (46)
2020 (45)
2024 (44)
2018 (44)
2023 (42)
2015 (40)
2025 (38)
2019 (34)
2017 (30)
2014 (28)
2013 (22)
2012 (16)
2011 (14)
2010 (12)
2008 (10)
2009 (9)
2026 (6)
2007 (2)
2006 (1)

Lab affiliation

Biological Mass Spectrometry Lab, Department of Translational Medicine (DiMeT), Center for Translational Research on Autoimmune & Allergic Diseases - CAAD - University of Piemonte Orientale, Corso Trieste 15/A, 28100, Novara, Italy (1)
Biomedical Research in Melanoma-Animal Models and Cancer Laboratory Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Hospital Barcelona-UAB Barcelona, 08035, Spain. (1)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada (1)
Clinical Research Division, Fred Hutchinson Cancer Reseaarch Center (1)
Department of Chemistry, Oregon State University, US (1)
Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany (1)
Department of Pharmaceutical Sciences, School of Pharmacy, University at Buffalo, Buffalo, New York, United States (1)
Department of Radiology Canary Center at Stanford for Cancer Early Detection Stanford School of Medicine Stanford University (1)
European Institute of Oncology (1)
Gottfried Schatz Research Center for Cell Signaling, Metabolism & Aging, Division of Cell Biology, Histology and Embryology, Medical University of Graz, 8010 Graz, Austria (1)
Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), 3000 Leuven, Belgium / Department of Obstetrics and Gynecology, University Hospitals Leuven and Department of Oncology, 3000 Leuven, Belgium / Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek-Netherlands Cancer Institute (AvL-NKI), University Medical Center (UMC), Amsterdam, The Netherlands (1)
Head, Department of Biochemistry and Molecular Biology, Monash University Head, Signalling Network Laboratory, Monash University Head, Biomedicine Discovery Institute Cancer Program, Monash University (1)
Hopp Children`s Cancer Center Heidelberg (KiTZ) National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Germany Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany (1)
Immunology Department, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland (1)
Institute of Plant Sciences, University of Bern, Bern, Switzerland (1)
Lineberger Comprehensive Cancer Center Department of Pharmacology UNC Chapel Hill Chapel Hill NC USA (1)
Oncology Research and Development, Pfizer Inc. (1)
Pediatric Hematology-Oncology Research Laboratory, Woman-Mother-Child Department, Lausanne University Hospital and University of Lausanne, Switzerland. (1)
Peking University Cancer Hospital & Institute. (1)
Professor of Chemistry Department of Chemistry Duke University (1)
Professor of protein technology, Department of Immunotechnology, Lund University, Lund, Sweden (1)
QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane QLD 4006, Australia (1)
Sunnybrook Research Institute, Toronto, ON, Canada / Department of Biochemistry, University of Toronto, Toronto, ON, Canada / Department of Biochemistry and Molecular Biology, Alberta Children’s Hospital Research Institute, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada / Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada (1)
The Institute of Cancer Research, London (1)

Previous page
1 / 94
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 94
Next page

Sort by:

Relevance

Page size

Promoter methylation in HNSCC tumor cell lines is significantly different from primary tumors and xenografts

This study focused on global methylation changes between tumors, normal mucosa, primary tumor xenografts, and cell lines in order to determine epigenetic changes in cell cultures and xenografts derived from primary tumors. 1 fully methylated control cell line, 1 fully demethylated control cell line,...

ORGANISM(S): Homo sapiens

2011-09-30 | E-GEOD-24787 | biostudies-arrayexpress

Cell-intrinsic metabolic phenotypes identified in glioblastoma patients using mass spectrometry imaging of 13C-labeled glucose metabolism

Transcriptomic studies attempted to classify glioblastoma (GB) into subtypes that predict survival and that have different therapeutic vulnerabilities1-3. Here we identified three metabolic subtypes: glycolytic, oxidative and a mixed glycolytic/oxidative by mass spectrometry imaging of rapidly ex...

2025-05-08 | MTBLS12176 | MetaboLights

LAMP2A WT and KO on cell line derived xenografts tumors

PRJEB83229 | ENA

Single-cell Gene Expression Flex analysis on cell line derived xenografts of PC9 cells treated with Osimertinib

PRJEB74450 | ENA

Single cell RNA sequencing analysis of freshly resected PC9 cell line-derived tumor xenografts

PRJNA672709 | ENA

Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts.

Not available

S-EPMC5029664 | biostudies-literature

Transcriptional profiling by array of pancreatic ductal adenocarcinoma xenograft models

We generated novel patient derived xenograft (PDX) and cell line -derived xenograft models for pancreatic ductal adenocarcinoma (PDAC) which reflect different molecular subtypes. Pancreatic ductal adenocarcinoma is currently the tumor with the fourth highest mortality rate. Recently, subtypes of PDA...

ORGANISM(S): Homo sapiens

2016-01-12 | E-MTAB-4029 | biostudies-arrayexpress

Genomic profiling of patient-derived xenografts identify high level â€œpassengerâ€ gene aberrations associated with better prognosis in non-small cell lung cancer

Patient-derived tumor xenografts (PDXs) increasingly are being used as preclinical models to study human cancers and to evaluate novel therapeutics, as they reflect clinical cancers more closely than established tumor cell lines. With >100 PDXs established from resected non-small cell lung carcinoma...

ORGANISM(S): Mus musculus

2016-10-26 | E-GEOD-68929 | biostudies-arrayexpress

Transcription profiling of human xenograft laboratory models and primary tumors of small cell lung cancer

Gene expression was measured on the Affymetrix platform in primary xenografts, xenograft-derived cell lines, secondary xenografts, normal lung, and primary tumors obtained from chemotherapy naive Small Cell Lung Cancer (SCLC). The SCLC primary xenografts were serially propagated in vivo in immunodef...

ORGANISM(S): Homo sapiens

2009-06-05 | E-GEOD-15240 | biostudies-arrayexpress

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

The neuroendocrine (NE) phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the NE phenotype in CRPC. Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and ...

ORGANISM(S): Homo sapiens

2015-06-24 | E-GEOD-66187 | biostudies-arrayexpress

Previous page
1 / 94
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 94
Next page

Sort by:

Relevance

Page size

939 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets